Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States
NAFLD exhibits high comorbidity with CKM syndrome, and the high prevalence of NAFLD at CKM 0 highlights early metabolic risk. NAFLD is not an independent mortality predictor but accelerates CKM progression to increased mortality.
Authors
- Wenjing Zhao (ORCID: https://orcid.org/0000-0003-4101-4065)
- Jian Liu (ORCID: https://orcid.org/0000-0003-3101-7553)
- Shiwei Qin
- Zhenghao Li
- Dongying Zhang
- Xuesong Wen (ORCID: https://orcid.org/0000-0002-3437-4452)
- Lei Gao (ORCID: https://orcid.org/0000-0002-3897-6362)
- Junlong Chen (ORCID: https://orcid.org/0000-0003-3931-8190)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Emergency Medical Center (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.ajpc.2025.101049
- Citations
- 7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 9.48